Certain Postapproval Requirements and Resources for ANDAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 4, 2026
June 4, 2026
114dc69b-dd6a-4c2f-88c6-0386cd92124f
Related Documents
ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs: Guidance for Industry
Guidance DocumentDecember 16, 2025Center for Drug Evaluation and Research
Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentDecember 22, 2025Center for Drug Evaluation and Research
Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use: Guidance for Industry
Guidance DocumentNovember 17, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox